glp-1 news today october 16 2025 Trump announces $50/month weight loss drugs for millions As GLP-1 Drugs Go Mainstream,
Description
There are currently two major players with a decisive head start in the obesity drug space: Eli Lilly (LLY) and Novo Nordisk (NVO)
Learn about the GLP-1 receptor agonist injections for weight management, including injection areas, technique, safety tips, and doctor supervision at The Clifford Clinic.
$149/mo all-inclusive, delivered to your door
Adequate dietary fiber intake supports cardiovascular, gastrointestinal and metabolic health
Are YOU safe?
The GLP-1 semaglutide (#Ozempic) failed to improve mood and executive functioning in this, the first RCT of a GLP-1 for major #depression: Weight loss was significant (all subjects were overweight/obese)
